Progenics Pharmaceuticals Inc. (PGNX): Price and Financial Metrics

Progenics Pharmaceuticals Inc. (PGNX)

Today's Latest Price: $4.61 USD

0.04 (-0.86%)

Updated Feb 14 12:00am

Add PGNX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 339 in Biotech

See all "A" rated Strong Buy stocks

PGNX Stock Summary

  • Of note is the ratio of Progenics Pharmaceuticals Inc's sales and general administrative expense to its total operating expenses; 25.86% of US stocks have a lower such ratio.
  • PGNX's price/sales ratio is 17.53; that's higher than the P/S ratio of 93.19% of US stocks.
  • Revenue growth over the past 12 months for Progenics Pharmaceuticals Inc comes in at 41.94%, a number that bests 87.72% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to Progenics Pharmaceuticals Inc, a group of peers worth examining would be RTRX, OMEX, APVO, CASA, and DNN.
  • PGNX's SEC filings can be seen here. And to visit Progenics Pharmaceuticals Inc's official web site, go to
PGNX Daily Price Range
PGNX 52-Week Price Range

PGNX Stock Price Chart More Charts

PGNX Price/Volume Stats

Current price $4.61 52-week high $6.37
Prev. close $4.65 52-week low $3.42
Day low $4.56 Volume 252,800
Day high $4.64 Avg. volume 641,423
50-day MA $4.88 Dividend yield N/A
200-day MA $4.99 Market Cap 398.41M

Progenics Pharmaceuticals Inc. (PGNX) Company Bio

Progenics Pharmaceuticals is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. The company was founded in 1986 and is based in Tarrytown, New York.

PGNX Latest News Stream

Event/TimeNews Detail
Loading, please wait...

PGNX Latest Social Stream

Loading social stream, please wait...

View Full PGNX Social Stream

PGNX Price Returns

1-mo -1.71%
3-mo -18.84%
6-mo 25.61%
1-year -5.92%
3-year -56.26%
5-year -21.33%
YTD -9.43%
2019 21.19%
2018 -29.41%
2017 -31.13%
2016 40.95%
2015 -18.92%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7218 seconds.